Cookies policy. You will see this message only once.
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we’ll assume that
you’re happy to receive all cookies on this site. However, if you would like to, you can
change your cookie settings at any time.
Find out more.
FDA News - Telaprevir and Boceprevir
On April 27th and 28th, the FDA Antiviral Drugs Advisory Committe met to discuss the new drug applications for telaprevir and boceprevir. Background materials for these applications have been made available and contain detailed information regarding the pharmacology and clincal studies for each of these drugs.
Boceprevir Briefing Document (Merck)
